Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of Multiple Dose of IBI3002 in Healthy and Asthmatic Participants [Phase 1]

View source ↗

Summary

Phase 1 study to evaluate safety and tolerability of multiple doses of IBI3002 in healthy and asthmatic participants; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• IBI3002

Snippet

Sponsor: Innovent Biologics (Suzhou) Co. Ltd. | Conditions: Asthma | Phase 1 | Status: RECRUITING